Astrazeneca Pharma India Ltd. Fundamental & Technical Research, Share Price Today

NSE : ASTRAZEN
NIFTY : Nifty 500

About Company

AstraZeneca Pharma India Limited (AZPIL) is the operating company and covers manufacturing, sales and marketing activities of the company in India. It is a listed company and is a subsidiary of AstraZeneca Plc, UK. The company is committed to deliver life-changing medicines to patients through innovative science and global excellence in development and commercialization. The company has an innovative portfolio in crucial areas of healthcare including cardiovascular, renal & metabolic diseases, oncology and respiratory. Rated as one of the finest in South East Asia, AstraZeneca’s Indian manufacturing facility has a sophisticated production facility designed to meet the most stringent international standards, conforming to WHO cGMP (current Good Manufacturing Practices) norms. The facility is an ISO 14001 certified company and has a full-fledged environment management system in place.

Market Cap. ₹19,672 Cr.

52 Week - High/Low ₹9,059/4,800

P/E Ratio 202.91

P/B Ratio 27.63

Enterprise Value ₹19,264 Cr.

ROE % 24.95

RSI Value 48.80

EMA 50 7652.35

EMA 200 6964.02

Net Profit 162 Cr.

Net Profit 3year growth 73.11 Cr.

Net Profit 3 year (back) 93 Cr.

Debt to Equity 0.0 %

EPS Growth TTM -30.41 %

Current Ratio 2.23 %

100 Day SMA 7,150 Rs.

200 Day SMA 7,071 Rs.

21 Day SMA 8,047 Rs.

50 Day SMA 7,550 Rs.

Book Value 285 Rs.

EV/EBITDA Ratio 121

QoQ EPS Growth -20 %

QoQ Operating Profit Growth -17 %

QoQ Sales Growth 8 %

Sales Latest Quarter 440 Cr.

YoY Sales Growth 44 %

Add Parameters

Valuation

Peer Comparison

Industry - Pharmaceuticals & Drugs

* Please refer to the Standalone data if Consolidated financial data for the company is not available.

Shareholding Pattern Numbers in percentages